References
- Swerdlow SH, Webber SA, Chadburn A, et al. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon (France): IARC Press; 2008. pp. 343–349.
- Dierickx D, Tousseyn T, Gheysens O. How I treat posttransplant lymphoproliferative disorders. Blood. 2015;126:2774–2783.
- Opelz G, Döhler B. HLA matching and kidney transplantation: beyond graft survival. Clin Transpl. 2013;27:121–126.
- McAulay KA, Jarrett RF. Human leucocyte antigens and genetic susceptibility to lymphoma. Tissue Antigens. 2015;86:98–113.
- Morscio J, Dierickx D, Tousseyn T. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? Clin Dev Immunol. 2013;2013:150835.
- Kinch A, Sundström C, Tufveson G, et al. Association between HLA-A1 and –A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder. Leuk Lymphoma. 2016;57:2351–2358. doi: 10.3109/10428194.2016.1173209.
- Hafez MM, el-Wehedy GF, el-Kholy NM, et al. The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma. Int J Cancer. 1985;36:19–22.
- Opelz G, Döhler B. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation. 2010;90:292–297.
- Opelz G, Döhler B. Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. Transplantation. 2010;89:567–572.
- Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation. 2007;84:137–143.